Online Neurobehavioral Therapy for Veterans with Epilepsy and Depression
Official title: Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
Run by The University of Texas Health Science Center, Houston · NCT06695767 · Data updated 2026-11-12
This study is testing an online therapy program with text messaging support to see if it helps veterans with epilepsy and depression feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 2 sites (Houston, Texas and 1 other locations) |
| Status | Recruiting |
| Started | December 19, 2024 |
| Main results expected | February 6, 2025 |
| Study ends | April 1, 2025 |
| Registry record updated | January 9, 2025 |
| Trial ID | NCT06695767 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are English-speaking veterans with internet access who have a clinical diagnosis of major depressive disorder and epilepsy.
✕Probably not a fit
Patients who are currently pregnant, experiencing suicidal ideation, or have active psychosis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the feasibility and acceptability of an online group Neurobehavioral Therapy (NBT) combined with a text messaging intervention specifically designed for veterans suffering from epilepsy and major depressive disorder (MDD). Participants will engage in therapy sessions conducted over the internet, utilizing their home internet access and mobile devices for communication. The study focuses on veterans who are asymptomatic but have chronic conditions, ensuring they have the necessary technology and support to participate effectively.
Why it matters
Potential benefit: If successful, this intervention could provide veterans with a novel and accessible treatment option for managing both epilepsy and major depressive disorder.
How similar studies have gone: While this approach is innovative, similar studies exploring online therapies for mental health conditions have shown promising results, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * English speaking veterans * has home internet access * has access to and familiarity in using a computer or tablet at least weekly * Asymptomatic patients with chronic conditions * has access to a mobile device with Short Message Service (SMS) text and picture capability * has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10) * has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years Exclusion Criteria: * pregnancy * Veterans that have current suicidal ideation * have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.
Where it's running
-
Michael E. DeBakey VA Medical Center
Houston, Texas, United States Recruiting -
The University of Texas health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Melissa Fadipe, MSN, APRN, FNP-C — The University of Texas Health Science Center, Houston
- Study coordinator: Melissa Fadipe, MSN, APRN, FNP-C
- Email: Melissa.F.Fadipe@uth.tmc.edu
- Phone: (713) 825-7237
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mapping how repeated brain stimulation changes neural activity using implanted and scalp recordings
This project will test whether repeated transcranial magnetic stimulation (TMS) changes brain activity in people with major depressive disorder or epilepsy by comparing direct recordings from implanted electrodes to noninvasive recordings.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Dupilumab for Major Depressive Disorder
This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.